CDH2 and neoplasm: Mesenchymal markers such as CDH2 (log2fc = 0.57) and DDR2 (log2fc = 0.63) are elevated in poor-prognosis tumours, suggesting that upregulation of mesenchymal genes may contribute to more aggressive tumour phenotypes.